Professor Don Jones

Professor Jones is the Current interim Head of School of Medical Sciences. He is also a co-director of the Leicester van Geest Multi-OMICs Facility, which is a world-leading centre for biomarker research (https://le.ac.uk/cardiovascular-sciences/research/biomarker-facility).

Professor Jones’ research involves discovering and implementing novel biomarkers of disease using mass spectrometry techniques, with particular interest in the discovery of biomarkers (proteins, metabolites and lipids) using state-of-the-art analytical techniques in combination with novel data interrogation techniques. From these projects the group are establishing targeted assays for biomarkers and working with pathology colleagues to validate and achieve clinical accreditation for assays.

Professor Jones was previously a Co-director of the Leicester Institute for Precision Health (IPH) which helps coalesce precision medicine activity across the University and NHS. All this work helps to underpin the implementation of precision medicine by finding novel tools to personalise diagnosis and treatment in modern medicine.

Professor Jones plays an active role in the NIHR Biomedical Research Centre which allows this research to be translated into clinical use.

Professor Donald Jones develops and applies advanced mass spectrometry and multi-omics technologies to understand the molecular basis of health and disease. His research integrates metabolomics, lipidomics, proteomics and exposomics to identify biomarkers, investigate disease mechanisms and measure the effects of environmental exposures. Working across laboratory, clinical and population settings, he develops robust analytical workflows for studies ranging from detailed biological experiments to large-scale cohorts such as UK Biobank. A key focus is translating complex molecular data into meaningful insights for cancer, cardiometabolic disease, neurodegeneration, ageing and therapeutic response.

Research themes

Advanced mass spectrometry and analytical technology development • Metabolomics, lipidomics, proteomics and integrated molecular phenotyping • Exposomics and the effects of environmental chemical and metal exposures • Population-scale biomarker discovery and molecular epidemiology • Reproducible, scalable workflows for clinical and translational research • Collaborative research spanning academia, healthcare and industry

1. Collier MEW, Cao TH, Quinn PA, Sandhu JK, Jones DJL, Goodall AH. Proteomic analysis of extracellular vesicles released from endothelial cells in vitro reveals increased levels of E-selectin and dual specificity phosphatase 7 as a potential marker of TNFα-mediated apoptosis. PLoS One. 2026 Jun 26;21(6):e0352394. doi: 10.1371/journal.pone.0352394. PMID: 42361017; PMCID: PMC13308812.
2. Collier MEW, Ceeney G, Chiappelli J, Korrapati S, Cao TH, Quinn P, Ma J, Shauriq A, Sylvius N, Hollox EJ, Jones DJL, Hudson A, Hong EL, Scrutton N, Schwarcz R, Giorgini F. The single nucleotide polymorphism rs1053230 modulates kynurenine 3-monooxygenase stability and is associated with cognitive and mood phenotypes. bioRxiv [Preprint]. 2026 May 21:2026.05.19.726163. doi: 10.64898/2026.05.19.726163. PMID: 42239117; PMCID: PMC13228610.
3. Alghamdi R, Osman H, Highton PJ, Fahad M, Salim F, Lane D, Bernieh D, Jenkins S, Pieri B, Smith OM, Gupta M, Ramesh P, Tomaszewski M, Samani NJ, Patel P, Khunti K, Mulla H, Jones DJL, Squire I, Gupta P. A literature review of the pharmacokinetic profiles of 20 commonly prescribed antihypertensive medications for use in chemical adherence testing. J Hypertens. 2026 Jul 1;44(7):1109-1115. doi: 10.1097/HJH.0000000000004333. Epub 2026 May 7. PMID: 42186443; PMCID: PMC13236028.
4. Maxwell CB, Lane D, Bhakta N, Brady EM, Haigh RD, Singh R, Gulsin GS, McCann GP, Ng LL, Jones DJL. Harnessing New Tools for Old Challenges: Optimising Neat Plasma Proteomics with Automation and Gas-Phase Fractionation. ACS Meas Sci Au. 2026 Jan 5;6(1):224-237. doi: 10.1021/acsmeasuresciau.5c00166. PMID: 41727364; PMCID: PMC12921592.
5. Konsue A, Gleeson D, Choowongkomon K, Jones DJL, Hannanta-Anan P, Britton RG,Gleeson MP. Computationally guided design of N4-(2-methyl-2H-indazol-6-yl)-N2-phenylpyrimidine-2,4-diamine inhibitors of EGFR kinase targeting Cys797. Bioorg Med Chem. 2026 Mar;134:118544. doi:10.1016/j.bmc.2025.118544. Epub 2026 Jan 2. PMID: 41518945.
6. Henson J, Ghit A, Tziannou A, James E, Edwardson CL, Bishop NC, Razieh C, Jones DJL, Cao TH, Davies MJ, Khunti K, Yates T. Proteomics insights: exploring the inflammatory and metabolic signatures of ethnicity and change in physical activity in non-diabetic hyperglycaemia. EBioMedicine. 2025 Nov;121:106006. doi:10.1016/j.ebiom.2025.106006. Epub 2025 Nov 3. PMID: 41187617; PMCID: PMC12677085.
7. Santos-Pujol E, Noguera-Castells A, Casado-Pelaez M, García-Prieto CA, Vasallo C, Campillo-Marcos I, Quero-Dotor C, Crespo-García E, Bueno-Costa A, Setién F, Ferrer G, Davalos V, Mereu E, Pluvinet R, Arribas C, Torre C,Villavicencio F, Sumoy L, Granada I, Coles NS, Acha P, Solé F, Mallo M, Mata C,Peregrina S, Gabaldón T, Llirós M, Pujolassos M, Carreras-Torres R, Lluansí A, García-Gil LJ, Aldeguer X, Samino S, Torné P, Ribalta J, Guardiola M, Amigó N,Yanes O, Martínez P, Sánchez-Vázquez R, Blasco MA, Oviedo J, Lemos B, Rius-BonetJ, Torrubiano M, Massip-Salcedo M, Khidir KA, Cao TH, Quinn PA, Jones DJL, Macip S, Brigos-Barril E, Moldes M, Barteri F, Muntané G, Laayouni H, Navarro A,Esteller M. The multiomics blueprint of the individual with the most extreme lifespan. Cell Rep Med. 2025 Oct 21;6(10):102368. doi:10.1016/j.xcrm.2025.102368. Epub 2025 Sep 24. PMID: 40997805; PMCID:

   PMC12629823.

8. Sandhu JK, Jones DJL, Maxwell CB, Gwinnell CL, Williams G, Cao TH, Quinn PA, Ng LL.Molecular Organ Lysate Imprinting: For Precision Recognition and Analysis of Organ-Derived Proteins. Rapid Commun Mass Spectrom. 2025 Dec 15;39(23):e10125. doi: 10.1002/rcm.10125. PMID: 40873137.
9. Kaewkham O, Gleeson D, Fukasem P, Santatiwongchai J, Jones DJL, Britton RG, Gleeson MP. Probing the Effect of Protein and Inhibitor Conformational Flexibility on the Reaction of Rocelitinib-Like Covalent Inhibitors of Epidermal Growth Factor Receptor. A Quantum Mechanics/Molecular Mechanics Study. J Chem Inf Model. 2025 Apr 14;65(7):3555-3567. doi: 10.1021/acs.jcim.4c01985. Epub 2025 Mar 18. PMID: 40100083; PMCID: PMC12004534.
10. Badillo-Sanchez DA, Jones DJL, Guellil M, Inskip SA, Scheib CL. Correction: Badillo-Sanchez et al. Human Archaeological Dentin as Source of Polar and Less Polar Metabolites for Untargeted Metabolomic Research: The Case of Yersinia pestis. Metabolites 2023, 13, 588. Metabolites. 2025 Mar 11;15(3):187. doi: 10.3390/metabo15030187. Erratum for: Metabolites. 2023 Apr 24;13(5):588. doi: 10.3390/metabo13050588. PMID: 40137177; PMCID: PMC11943891.
11. Rothwell B, Cooper CR, Jones DJL, Merchant MJ, Kirkby NF, Kirkby KJ, Petersson K, Schuemann J, Jones GDD. FLASH-induced DNA damage reduction measured in vitro correlates with effective oxygen depletion determined in silico: further support for oxygen depletion contributing to FLASH's reduced damage burden in vitro. Br J Radiol. 2025 Jul 1;98(1171):1032-1037. doi: 10.1093/bjr/tqaf097. PMID: 40326707; PMCID: PMC12202011.
12. Alraddadi A, Smalley JP, Alzahrani W, Saleh A, Al-Mansour F, He B, Cao TH, Jayne S, Dyer M, Hodgkinson JT, Jones DJL, Cowley SM, Macip S. Targeted Degradation of Class 1 HDACs With PROTACs is Highly Effective at Inducing DLBCL Cell Death. EJHaem. 2025 Aug 12;6(4):e70127. doi: 10.1002/jha2.70127. PMID: 40801055; PMCID: PMC12342057.
13. Bate N, Lane D, Evans SE, Salim F, Allcock NS, Haigh R, Sale JE, Jones DJL, Brindle NPJ.

    Engineered Receptor Capture Combined with Mass Spectrometry Enables High-Throughput Detection and Quantitation of SARS-CoV-2 Spike Protein. JACS Au. 2025 Feb 4;5(2):747-755. doi: 10.1021/jacsau.4c00980. eCollection 2025 Feb 24.

14. Maxwell CB, Bhakta N, Denniff MJ, Sandhu JK, Kessler T, Ng LL, Jones DJL, Webb TR, Morris GE.

    Deep plasma and tissue proteome profiling of knockout mice reveals pathways associated with Svep1 deficiency. J Mol Cell Cardiol Plus. 2025 Jan 10;11:100283. doi: 10.1016/j.jmccpl.2025.100283. eCollection 2025 Mar.

15. Badillo-Sanchez D, Davies-Barrett AM, Ruber MS, Jones DJL, Inskip SA. Archaeometabolomics characterizes phenotypic differences in human cortical bone at a molecular level relating to tobacco use. Sci Adv. 2024 Oct 4;10(40):eadn9317. doi: 10.1126/sciadv.adn9317. Epub 2024 Oct 4.
16. Konsue A, Lamtha T, Gleeson D, Jones DJL, Britton RG, Pickering JD, Choowongkomon K, Gleeson MP. Design, preparation and biological evaluation of new Rociletinib-inspired analogs as irreversible EGFR inhibitors to treat non-small-cell-lung cancer. Bioorg Med Chem. 2024 Sep 7;113:117906. doi: 10.1016/j.bmc.2024.117906.
17. Bhakta N, Maxwell CB, Atunde S, Sandhu JK, Slingsby OC, Brady EM, Jones DJL, Ng LL. An optimised method to isotopically label pure synthetic peptides 'in-house' for absolute quantification in bottom-up proteomics. Rapid Commun Mass Spectrom. 2024 Nov 30;38(22):e9892. doi: 10.1002/rcm.9892. PMID: 39287025
18. Wenzl FA, Wang P, Arrigo M, Parenica J, Jones DJL, Bruno F, Tarnwski D, Hartmann O, Boucek L, Lang F, Obeid S, Schober A, Kraler S, Akhmedov A, Kahles F, Schober A, Ow KW, Ministrini S, Camici GG, Bergmann A, Liberale L, Jarkovsky J, Schweiger V, Sandhu JK, von Eckardstein A, Templin C, Muller O, Ondrus T, Olic JJ, Roffi M, Räber L, Cao TH, Jungbauer CG, Ng LL, Mebazaa A, Lüscher TF. Proenkephalin Improves Cardio-Renal Risk Prediction in Acute Coronary Syndromes: The KID-ACS Score. Eur Heart J. 2024 Aug 31:ehae602. doi: 10.1093/eurheartj/ehae602. Online ahead of print.
19. Cao TH, Tay TW, Jones DJL, Cleland, JGF Tromp J, Emmens JE, Teng THK, Chandramouli C, Anker SD,Dickstein K, Filippatos G, Hillege HL, Lang CC, Metra M, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zannad F, Anand IS, Lam CSP, Voors AA, Ng LL. Heart failure with improved versus persistently reduced left ventricular ejection fraction: a comparison of the BIOSTAT-CHF (European) and ASIAN-HF Registry

    European Journal of Heart Failure. Accepted July 01 2024.

20. Williams G, Couchman L, Taylor DR, Sandhu JK, Slingsby OC, Ng LL, Moniz CF, Jones DJL, Maxwell CB.

    Use of Nonhuman Sera as a Highly Cost-Effective Internal Standard for Quantitation of Multiple Human Proteins Using Species-Specific Tryptic Peptides: Applicability in Clinical LC-MS Analyses. J Proteome Res. 2024 Mar 27. doi: 10.1021/acs.jproteome.3c00762. Online ahead of print. PMID: 38533909

21. Lane D, Allsopp R, Holmes CW, Slingsby OC, Jukes-Jones R, Bird P, Anderson NL, Razavi M, Yip R, Pearson TW, Pope M, Khunti K, Doykov I, Hällqvist J, Mills K, Skipp P, Carling R, Ng L, Shaw J, Gupta P, Jones DJL. A high throughput immuno-affinity mass spectrometry method for detection and quantitation of SARS- CoV-2 nucleoprotein in human saliva and its comparison with RT-PCR, RT-LAMP, and lateral flow rapid antigen test. Clin Chem Lab Med. 2024 Jan 23. doi: 10.1515/cclm-2023-0243. Epub ahead of print. PMID: 38253336.
22. Piletsky SS, Baidyuk E, Piletska EV, Lezina L, Shevchenko K, Jones DJL, Cao TH, Singh R, Spivey AC, Aboagye EO, Piletsky SA, Barlev NA. Modulation of EGFR Activity by Molecularly Imprinted Polymer Nanoparticles Targeting Intracellular Epitopes. Nano Lett. 2023 Nov 8;23(21):9677-9682. doi: 10.1021/acs.nanolett.3c01374. Epub 2023 Oct 30. PMID: 37902816; PMCID: PMC10636853.
23. Badillo-Sanchez D, Serrano Ruber M, Davies-Barrett A, Jones DJL, Hansen M, Inskip S. Metabolomics in archaeological science: A review of their advances and present requirements. Sci Adv. 2023 Aug 11;9(32):eadh0485. doi: 10.1126/sciadv.adh0485. Epub 2023 Aug 11. PMID: 37566664; PMCID: PMC10421062.
24. Badillo-Sanchez DA, Jones DJL, Inskip SA, Scheib CL. Human Archaeological Dentin as Source of Polar and Less Polar Metabolites for Untargeted Metabolomic Research: The Case of Yersinia pestis. Metabolites. 2023 Apr 24;13(5):588. doi: 10.3390/metabo13050588. PMID: 37233629; PMCID: PMC10223108.
25. Maxwell CB, Sandhu JK, Cao TH, McCann GP, Ng LL, Jones DJL. The Edge Effect in High-Throughput Proteomics: A Cautionary Tale. J Am Soc Mass Spectrom. 2023 Jun 7;34(6):1065-1072. doi: 10.1021/jasms.3c00035. Epub 2023 May 8. PMID: 37155737; PMCID: PMC10251511.
26. Cooper CR, Jones DJL, Jones GDD, Petersson K. Comet Assay Profiling of FLASH- Induced Damage: Mechanistic Insights into the Effects of FLASH Irradiation. Int J Mol Sci. 2023 Apr 13;24(8):7195. doi: 10.3390/ijms24087195. PMID: 37108360; PMCID: PMC10138874.
27. Badillo-Sanchez D, Ruber MS, Davies-Barrett AM, Sandhu JK, Jones DJL, Hansen M, Inskip SA. Examination of human osteoarchaeological remains as a feasible source of polar and apolar metabolites to study past conditions. Sci Rep. 2023 Jan 13;13(1):696. doi: 10.1038/s41598-023-27401-0. PMID: 36639564; PMCID: PMC9839756.
28. Piletska E, Thompson D, Jones R, Cruz AG, Poblocka M, Canfarotta F, Norman R, Macip S, Jones DJL, Piletsky S. Snapshot imprinting as a tool for surface mapping and identification of novel biomarkers of senescent cells. Nanoscale Adv. 2022 Oct 12;4(24):5304-5311. doi: 10.1039/d2na00424k. PMID: 36540121; PMCID: PMC9724690.
29. Hällqvist J, Lane D, Shapanis A, Davis K, Heywood WE, Doykov I, Śpiewak J, Ghansah N, Keevil B, Gupta P, Jukes-Jones R, Singh R, Foley D, Vissers JPC, Pattison R, Ferries S, Wardle R, Bartlett A, Calton LJ, Anderson L, Razavi M, Pearson T, Pope M, Yip R, Ng LL, Nicholas BI, Bailey A, Noel D, Dalton RN, Heales S, Hopley C, Pitt AR, Barran P, Jones DJL, Mills K, Skipp P, Carling RS. Operation Moonshot: rapid translation of a SARS-CoV-2 targeted peptide immunoaffinity liquid chromatography-tandem mass spectrometry test from research into routine clinical use. Clin Chem Lab Med. 2022 Nov 17;61(2):302-310. doi: 10.1515/cclm-2022-1000. PMID: 36395058.
30. Piletska E, Magumba K, Joseph L, Garcia Cruz A, Norman R, Singh R, Tabasso AFS, Jones DJL, Macip S, Piletsky S. Molecular imprinting as a tool for determining molecular markers: a lung cancer case. RSC Adv. 2022 Jun 15;12(28):17747-17754. doi: 10.1039/d2ra01830f. PMID: 35765329; PMCID: PMC9200412.
31. Lane D, Lawson A, Burns A, Azizi M, Burnier M, Jones DJL, Kably B, Khunti K, Kreutz R, Patel P, Persu A, Spiering W, Toennes SW, Tomaszewski M, Williams B, Gupta P, Dasgupta I; Endorsed by the European Society of Hypertension (ESH) Working Group on Cardiovascular Pharmacotherapy and Adherence. Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence Testing. Hypertension. 2022 Jan;79(1):12-23. doi: 10.1161/HYPERTENSIONAHA.121.17596. Epub 2021 Nov 5. PMID: 34739765.
32. Piletsky SA, Bedwell TS, Paoletti R, Karim K, Canfarotta F, Norman R, Jones DJL, Turner NW, Piletska EV. Modulation of acetylcholinesterase activity using molecularly imprinted polymer nanoparticles. J Mater Chem B. 2022 Mar 31. doi: 10.1039/d2tb00278g. Online ahead of print.
33. Alaqbi SS, Burke L, Guterman I, Green C, West K, Palacios-Gallego R, Cai H, Alexandrou C, Myint NNM, Parrott E, Howells LM, Higgins JA, Jones DJL, Singh R, Britton RG, Tufarelli C, Thomas A, Rufini A. Increased mitochondrial proline metabolism sustains proliferation and survival of colorectal cancer cells. PLoS One. 2022 Feb 7;17(2):e0262364. doi: 10.1371/journal.pone.0262364. eCollection 2022.PMID: 35130302
34. Jones DJL, Singh R, Emms V, Farmer PB, Grant D, Quinn P, Maxwell C, Mina A, Ng LL, Schumacher S, Britton RG.Determination of N7-glycidamide guanine adducts in human blood DNA following exposure to dietary acrylamide using liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2022 Mar 30;36(6):e9245. doi: 10.1002/rcm.9245.PMID: 34939243
35. Piletsky SS, Piletska E, Poblocka M, Macip S, Jones DJL, Braga M, Cao TH, Singh R, Spivey AC, Aboagye EO, Piletsky SA. Snapshot imprinting: rapid identification of cancer cell surface proteins and epitopes using molecularly imprinted polymers Nano Today 2021 41. 10.1016/j.nantod.2021.101304
36. Norman RL, Singh R, Muskett FW, Parrott EL, Rufini A, Langridge JI, Runau F, Dennison A, Shaw JA, Piletska E, Canfarotta F, Ng LL, Piletsky S, Jones DJL. Mass spectrometric detection of KRAS protein mutations using molecular imprinting. Nanoscale. 2021 Dec 16;13(48):20401-20411. doi: 10.1039/d1nr03180e. PMID: 34854867
37. Van Puyvelde B, ……….. Jones DJL, Gupta P, Lane D, ……et al. Cov-MS: A Community-Based Template Assay for Mass-Spectrometry-Based Protein Detection in SARS-CoV-2 Patients. JACS Au. 2021 Jun 28;1(6):750-765. doi: 10.1021/jacsau.1c00048. Epub 2021 May 3.PMID: 34254058
38. Gupta P, Voors AA, Patel P, Lane D, Anker SD, Cleland JGF, Dickstein K, Filippatos G, Lang CC, van Veldhuisen DJ, Metra M, Zannad F, Samani NJ, Jones DJL, Squire IB, Ng LL. Non-adherence to heart failure medications predicts clinical outcomes: Assessment in a single spot urine sample by liquid chromatography - tandem mass spectrometry (results of a prospective multicentre study). Eur J Heart Fail. 2021 Mar 23. doi: 10.1002/ejhf.2160. Epub ahead of print. PMID: 33759308.
39. Israr MZ, Bernieh D, Salzano A, Cassambai S, Yazaki Y, Heaney LM, Jones DJL, Ng LL, Suzuki T. Association of gut-related metabolites with outcome in acute heart failure. Am Heart J. 2021 Apr;234:71-80. doi: 10.1016/j.ahj.2021.01.006. Epub 2021 Jan 14. PMID: 33454370.
40. Runau F, Arshad A, Isherwood JD, Sandhu JK, Ng LL, Dennison AR, Jones DJL. Proteomic Characterization of Circulating Molecular Perturbations Associated With Pancreatic Adenocarcinoma Following Intravenous ω-3 Fatty Acid and Gemcitabine Administration: A Pilot Study. JPEN J Parenter Enteral Nutr. 2020 Jul 27. doi: 10.1002/jpen.1952. Epub ahead of print. PMID: 32716569.
41. Norman RL, Singh R, Langridge JI, Ng LL, Jones DJL. The measurement of KRAS G12 mutants using multiplexed selected reaction monitoring and ion mobility mass spectrometry. Rapid Commun Mass Spectrom. 2020 Sep;34 Suppl 4(Suppl 4):e8657. doi: 10.1002/rcm.8657. Epub 2020 Feb 14. PMID: 31800120; PMCID: PMC7539944.
42. Cao TH, Jones DJL, et al.Plasma proteomic approach in patients with heart failure: insights into pathogenesis of disease progression and potential novel treatment targets. Eur J Heart Fail. 2020 Jan;22(1):70-80. doi: 10.1002/ejhf.1608. Epub 2019 Nov 6. PMID: 31692186; PMCID: PMC7028019.
43. Kanagala P, Squire IB, Jones DJL, et al.; GREAT (Global REsearch on Acute Conditions Team) Network. Proenkephalin and prognosis in heart failure with preserved ejection fraction: a GREAT network study. Clin Res Cardiol. 2019 Aug;108(8):940-949. doi: 10.1007/s00392-019-01424-y. Epub 2019 Feb 14. PMID: 30767059; PMCID: PMC6652170.
44. Tabasso AFS, Jones DJL, Jones GDD, Macip S. Radiotherapy-Induced Senescence and its Effects on Responses to Treatment. Clin Oncol (R Coll Radiol). 2019 May;31(5):283-289. doi: 10.1016/j.clon.2019.02.003. Epub 2019 Feb 27.
45. Cao TH, Jones DJL, et al. Using matrix assisted laser desorption ionisation mass spectrometry (MALDI- MS) profiling in order to predict clinical outcomes of patients with heart failure. Clin Proteomics. 2018 Nov 2;15:35. doi: 10.1186/s12014-018-9213-1. PMID: 30410428; PMCID: PMC6214161.
46. Emmens JE, Jones DJL, et al. Proteomic diversity of high-density lipoprotein explains its association with clinical outcome in patients with heart failure. Eur J Heart Fail. 2018 Feb;20(2):260-267. doi: 10.1002/ejhf.1101. Epub 2017 Dec 18. PMID: 29251807.
47. Ng LL, Squire IB, Jones DJL, et al. ; GREAT Network. Proenkephalin, Renal Dysfunction, and Prognosis in Patients With Acute Heart Failure: A GREAT Network Study. J Am Coll Cardiol. 2017 Jan 3;69(1):56-69. doi: 10.1016/j.jacc.2016.10.038. PMID: 28057251.
48. Mbasu RJ, Heaney LM, Molloy BJ, Hughes CJ, Ng LL, Vissers JP, Langridge JI, Jones DJL. Advances in quadrupole and time-of-flight mass spectrometry for peptide MRM based translational research analysis. Proteomics. 2016 Aug;16(15-16):2206-20. doi: 10.1002/pmic.201500500. Epub 2016 Jul 28. PMID: 27214876
49. Couchman L, Jones DJL, Moniz CF. The use of turbulent flow chromatography for rapid, on-line analysis of tryptic digests. Rapid Commun Mass Spectrom. 2015 Nov 30;29(22):2140-6. doi: 10.1002/rcm.7371. PMID: 26467226
50. Norris L, Malkar A, Horner-Glister E, Hakimi A, Ng LL, Gescher AJ, Creaser C, Sale S, Jones DJL. Search for novel circulating cancer chemopreventive biomarkers of dietary rice bran intervention in Apc(Min) mice model of colorectal carcinogenesis, using proteomic and metabolic profiling strategies. Mol Nutr Food Res. 2015 Sep;59(9):1827-36. doi: 10.1002/mnfr.201400818. Epub 2015 Jun 30. PMID: 26033951
51. Ng LL, Sandhu JK, Narayan H, Quinn PA, Squire IB, Davies JE, Struck J, Bergmann A, Maisel A, Jones DJL. Pro-substance p for evaluation of risk in acute myocardial infarction. J Am Coll Cardiol. 2014 Oct 21;64(16):1698-707. doi: 10.1016/j.jacc.2014.05.074. PMID: 25323258.

Professor Jones supervises projects on:

• Mass spectrometric techniques for biomarker discovery and quantification.
• Informatic techniques for biomarker research
• Quantitative Proteomics
• Metabolomics

Professor Jones teaches the following modules:

• MSc in Cancer Molecular Pathology and Therapeutics. MB7402
• MSc Immunity and Inflammation. MB7319

• Biomarkers of disease
• Precision Medicine
• Mass Spectrometry